poorli
understood
studi
use
ex
vivo
invas
assay
popul
genet
analys
investig
involv
complement
receptor
p
vivax
invas
first
observ
p
vivax
invas
reticulocyt
consist
reduc
surfac
express
reduc
enzymat
cleavag
presenc
natur
cell
compar
cell
addit
solubl
known
inhibitor
p
falciparum
invas
immunoprecipit
experi
p
vivax
reticulocyt
bind
protein
show
evid
complex
format
addit
analysi
genet
data
worldwid
human
popul
differ
exposur
malaria
parasit
show
significantli
higher
frequenc
allel
associ
low
receptor
express
surfac
rbc
higher
linkag
disequilibrium
human
popul
expos
p
vivax
malaria
compar
unexpos
popul
result
consist
posit
select
allel
vivaxendem
area
collect
find
demonstr
avail
surfac
rbc
modul
p
vivax
plasmodium
vivax
widespread
human
malaria
parasit
outsid
subsaharan
africa
billion
peopl
risk
infect
ten
million
case
everi
year
asexu
cycl
parasit
human
blood
invad
grow
multipli
insid
young
red
blood
cell
rbc
burst
schizont
stage
releas
merozoit
blood
circul
invad
new
reticulocyt
rbc
invas
complex
multistep
process
involv
merozoit
attach
apic
reorient
tight
junction
format
host
cell
invagin
penetr
addit
requir
orchestr
multipl
ligandreceptor
interact
throughout
differ
step
process
mani
parasitehost
interact
engag
invas
character
wellestablish
cultur
techniqu
advanc
genet
technolog
plasmodium
falciparum
research
p
vivax
invas
mechan
continu
lag
behind
owe
lack
reliabl
longterm
vitro
cultur
system
depend
continu
sourc
reticulocyt
deeper
understand
mechan
involv
process
p
vivax
invas
essenti
design
meaning
strategi
prevent
p
vivax
infect
howev
wellcharacter
essenti
ligandreceptor
interact
identifi
date
duffi
antigen
receptor
chemokin
darc
rbc
p
vivax
duffi
bind
protein
pvdbp
p
vivax
infect
rare
subsaharan
african
popul
silenc
mutat
duffi
blood
group
present
near
fixat
level
howev
recent
report
p
vivax
infect
duffyneg
individu
togeth
recent
describ
receptorligand
interact
potenti
parasit
ligand
unknown
receptor
paint
much
complex
scenario
multipl
hostparasit
interact
yet
well
character
reticulocyt
matur
rbc
membran
goe
intens
remodel
surfac
process
result
signific
reduct
loss
receptor
complement
receptor
type
transmembran
protein
whose
express
reduc
reticulocyt
matur
immuneregulatori
role
complement
activ
remov
immun
complex
blood
circul
also
known
receptor
p
falciparum
invas
bind
parasit
ligand
roset
interact
parasit
erythrocyt
membran
protein
level
surfac
rbc
genet
determin
low
l
high
h
express
allel
result
product
high
hh
medium
hl
low
level
two
snp
snp
linkag
disequilibrium
ld
caucasian
african
associ
low
express
protect
sever
p
falciparum
malaria
report
epidemiolog
studi
other
illustr
complex
relationship
suscept
p
falciparum
infect
diseas
best
knowledg
involv
p
vivax
invas
yet
investig
hypothes
surfac
reticulocyt
involv
p
vivax
invas
polymorph
gene
associ
low
express
posit
select
p
vivaxexpos
popul
protect
effect
ie
abil
decreas
effici
p
vivax
invas
explor
hypothesi
perform
ex
vivo
invas
assay
differ
experiment
condit
investig
signal
posit
select
gene
use
snp
data
worldwid
popul
cleavag
red
blood
cell
receptor
extens
use
investig
invas
pathway
p
falciparum
parasit
investig
profil
p
vivax
invas
reticulocyteenrich
rbc
rerbc
figur
treat
neuraminidas
remov
sialic
acid
residu
trypsin
cleav
sever
unknown
receptor
addit
chymotrypsin
cleav
sever
unknown
receptor
addit
darc
effici
cleavag
confirm
flow
cytometri
follow
antibodi
label
antibodi
fig
capac
treat
cell
invas
confirm
p
falciparum
strain
fig
result
agreement
previou
find
p
vivax
invas
reduc
sd
n
isol
sign
rank
p
neuraminidas
treatment
sd
n
isol
sign
rank
p
rang
trypsin
treatment
sd
n
isol
sign
rank
p
chymotrypsin
treatment
fig
tabl
result
demonstr
p
vivax
invas
sensit
treatment
chymotrypsin
trypsin
latest
reduc
p
vivax
invas
effici
half
presenc
intact
darc
suggest
one
trypsinsensit
receptor
eg
involv
process
p
vivax
invas
hand
although
p
vivax
invas
significantli
affect
neuraminidas
treatment
potenti
interact
role
sialic
acid
receptor
exclud
deserv
explor
futur
assay
express
surfac
rbc
vari
among
individu
variat
correl
exon
intron
snp
nonafrican
popul
test
whether
avail
surfac
reticulocyt
affect
effici
p
vivax
invas
character
exon
genotyp
express
level
surfac
rerbc
sampl
fig
tabl
identifi
seven
homozygot
hh
six
heterozygot
hl
rerbc
sampl
exon
snp
fig
wwwnaturecomscientificreport
wwwnaturecomscientificreport
invas
compar
invas
rate
rerbc
sampl
express
high
level
high
n
mean
mfi
sd
sampl
express
lowest
level
low
n
mfi
level
express
rerbc
sampl
significantli
lower
rerbc
sampl
p
reticulocyt
enrich
level
rerbc
sampl
sampl
significantli
differ
p
addit
rerbc
express
similar
level
surfac
rerbc
duffi
b
collect
result
suggest
differ
express
level
either
duffi
receptor
low
high
compar
rerbc
sampl
agreement
previou
observ
p
falciparum
invas
neuraminidasetr
untreat
rerbc
mfi
lower
rerbc
mean
mfi
sd
p
fig
demonstr
valid
experiment
system
p
vivax
invas
singl
rerbc
sampl
perform
use
n
isol
sd
sign
rank
p
lower
rerbc
sampl
fig
result
consist
role
mediat
p
vivax
invas
addit
sampl
would
necessari
demonstr
whether
impair
invas
attribut
level
test
role
p
vivax
invas
perform
invas
assay
presenc
solubl
recombin
protein
previou
studi
demonstr
laboratori
condit
incub
neuraminidasetr
rbc
block
p
falciparum
invas
case
incub
neuraminidasetr
rerbc
tabl
reduc
p
falciparum
invas
confirm
previou
result
fig
case
p
vivax
incub
rerbc
significantli
reduc
invas
sd
n
isol
sign
rank
p
fig
result
indic
directli
bind
unrecogn
p
vivax
ligand
interact
reduc
bind
p
vivax
parasit
nativ
reticulocyt
observ
reduct
invas
capac
compar
observ
rerbc
compar
wwwnaturecomscientificreport
wwwnaturecomscientificreport
lack
bind
recombin
p
vivax
pvrbp
parasit
ligand
pvrbp
homologu
pfrh
famili
p
falciparum
known
bind
mediat
glycophorin
independ
parasit
invas
previou
result
indic
role
p
vivax
invas
question
member
pvrbp
famili
might
correspond
p
vivax
parasit
ligand
test
hypothesi
perform
immunoprecipit
experi
use
kda
five
recombin
pvrbp
fragment
migrat
kda
respect
reduc
condit
fig
monoclon
success
immunoprecipit
saw
evid
complex
format
pvrbp
fragment
test
wwwnaturecomscientificreport
wwwnaturecomscientificreport
suggest
pvrbp
direct
ligand
hand
expect
observ
monoclon
success
immunoprecipit
complex
bias
distribut
l
allel
frequenc
area
p
vivax
transmiss
observ
reduc
avail
rerbc
decreas
effici
p
vivax
invas
even
presenc
intact
darc
therefor
hypothes
genotyp
associ
reduc
express
surfac
reticulocyt
may
confer
protect
p
vivax
infect
possibl
reflect
posit
select
l
allel
area
expos
histori
exposur
vivax
malaria
posit
select
one
allel
detect
unusu
fast
increas
allel
frequenc
one
popul
rel
anoth
extend
ld
surround
allel
interest
explor
hypothesi
investig
frequenc
allel
associ
phenotyp
metaanalysi
peerreview
articl
publicli
avail
data
first
confirm
ld
r
exon
intron
allel
popul
sampl
within
genom
project
tabl
use
data
mine
publicli
avail
databas
identifi
snp
intron
ld
r
exon
nonafrican
popul
tabl
ld
exon
intron
confirm
genotyp
sampl
vietnam
thailand
greec
belgium
peru
brazil
includ
intron
analysi
allel
frequenc
target
addit
genotyp
data
popul
exon
intron
data
avail
analyz
worldwid
distribut
allel
intron
exon
intron
hereaft
refer
allel
total
data
mine
inhous
genotyp
retriev
allel
data
individu
locat
across
countri
fig
tabl
first
compar
mean
allel
frequenc
malariafre
area
defin
area
document
histori
malaria
name
orkney
island
uk
xinjiang
provinc
china
siberia
vologda
russia
rang
mean
frequenc
report
popul
analysi
tabl
observ
significantli
increas
frequenc
area
p
vivax
exposur
p
subsaharan
popul
fig
stabl
transmiss
p
vivax
parasit
p
falciparum
parasit
respons
overal
transmiss
malaria
diseas
signific
increas
frequenc
figur
overlap
report
transmiss
intens
p
vivax
global
popul
signific
increas
allel
frequenc
still
observ
compar
mean
frequenc
african
popul
fig
b
figur
mean
rang
popul
expos
p
vivax
alon
p
falciparum
p
result
indic
posit
select
allel
vivaxendem
area
ld
decay
locu
posit
select
exon
assess
ld
analysi
use
data
genom
project
phase
estim
number
proxi
snp
snp
ld
exon
physic
distanc
ld
indic
nonrandom
associ
allel
multipl
loci
observ
significantli
higher
number
snp
r
popul
expos
p
vivax
malaria
ie
popul
east
asia
n
south
asia
n
europ
n
south
central
america
n
compar
african
popul
expos
p
vivax
malaria
n
p
fig
addit
ld
decay
result
genet
recombin
around
exon
snp
significantli
faster
popul
africa
kb
bp
bp
vivaxexpos
area
america
europ
asia
kb
bp
bp
p
fig
control
popul
stratif
shown
figur
supplementari
inform
p
vivax
reticulocyt
invas
essenti
process
character
cascad
event
involv
specif
hostparasit
interact
poorli
understood
result
ex
vivo
invas
assay
popul
genet
analys
indic
avail
reticulocyt
surfac
modul
p
vivax
invas
even
presenc
intact
darc
difficulti
associ
investig
p
vivax
invas
mechan
due
inabl
continu
cultur
parasit
vitro
limit
ex
vivo
invas
assay
extens
discuss
elsewher
brief
sever
limit
taken
account
perform
p
vivax
invas
assay
low
parasit
densiti
fieldclin
isol
p
vivax
parasit
densiti
need
ensur
success
invas
high
proport
ring
necessari
success
invas
ex
vivo
adapt
extrem
variabl
parasit
isol
may
partial
explain
inher
characterist
parasit
sever
sampl
produc
high
proport
gametocyt
matur
process
thu
discard
cryopreserv
parasit
show
lower
invas
effici
fresh
isol
limit
number
p
vivax
isol
correct
criteria
perform
exvivo
invas
assay
number
sampl
matur
success
present
optim
invas
rate
untreat
control
well
togeth
need
reduc
assay
variabl
greatli
limit
number
condit
test
one
parasit
isol
nevertheless
recent
increas
number
public
use
p
vivax
ex
vivo
assay
demonstr
use
tool
investig
molecular
mechan
relat
parasit
invas
experi
use
cryopreserv
p
vivax
isol
reticulocyteenrich
sampl
hemochromatosi
donor
regard
avail
rerbc
confirm
flow
cytometri
demonstr
abil
p
vivax
isol
invad
heterogen
popul
variabl
level
addit
invas
rate
observ
compar
rate
previous
report
differ
reticulocyt
sou
rce
final
observ
consist
signific
invas
inhibit
differ
experi
use
natur
express
variat
rerbc
biochem
approach
modifi
presenc
rerbc
surfac
regard
find
decreas
p
vivax
invas
trypsintr
cell
contradict
previou
wwwnaturecomscientificreport
wwwnaturecomscientificreport
observ
although
trypsinsensit
vitro
bind
demonstr
critic
recognit
reticulocyt
p
vivax
invas
discrep
previou
studi
least
partial
explain
differ
experiment
condit
barnwel
et
al
sourc
enrich
proport
use
reticulocyt
unknown
author
use
singl
p
vivax
belem
strain
maintain
squirrel
monkey
invas
monitor
hour
incub
inform
invas
rate
lack
comparison
malleret
et
al
use
mg
trypsin
digest
treatment
use
higher
concentr
prove
flow
cytomet
remov
surfac
reticulocyt
overal
although
demonstr
invas
inhibit
antibodi
may
strengthen
find
result
provid
strong
support
involv
process
p
vivax
invas
role
support
observ
signific
increas
frequenc
l
allel
strong
ld
around
exon
snp
popul
p
vivax
histor
major
malaria
speci
compar
popul
area
without
vivax
exposur
african
contin
allel
associ
low
phenotyp
may
exert
benefici
effect
popul
expos
p
vivax
reduc
effici
invas
thu
decreas
risk
infect
diseas
allel
frequenc
ld
measur
correl
well
popul
recent
exposur
p
vivax
parasit
mediterranean
asian
american
pacif
popul
effect
allel
frequenc
faster
dilut
popul
past
exposur
migrat
movement
nonmediterranean
european
popul
popul
differenti
extend
ld
genom
region
alreadi
report
sardinian
popul
long
histori
endem
malaria
shortli
world
war
ii
indic
posit
natur
select
popul
author
propos
p
falciparum
select
forc
locu
inde
mani
studi
report
import
role
malaria
infect
pathogenesi
although
investig
associ
p
falciparum
suscept
depict
tabl
linkag
disequilibrium
exon
intron
global
popul
snp
data
retriev
genom
project
databas
inhous
genotyp
linkag
disequilibrium
analyz
use
ldlink
softwar
tool
cubex
softwar
tool
inhous
genotyp
data
wwwnaturecomscientificreport
wwwnaturecomscientificreport
complex
scenario
discrep
result
contradictori
result
may
explain
multipl
factor
includ
differ
genet
background
popul
pleiotrop
effect
differ
diseas
promiscu
use
receptor
p
falciparum
parasit
invas
roset
complex
factor
influenc
level
african
popul
result
studi
indic
select
pressur
exert
p
vivax
malaria
studi
previous
demonstr
role
p
vivax
infect
shape
human
genom
includ
studi
duffi
determin
african
individu
south
east
asian
ovalocytosi
papua
new
guinea
wwwnaturecomscientificreport
wwwnaturecomscientificreport
addit
trypsinsensit
p
vivax
invas
observ
modest
albeit
nonsignific
reduct
invas
effici
neuraminidasetr
cell
potenti
role
sialyl
glycoprotein
p
vivax
reticulocyt
invas
investig
deserv
attent
final
unabl
demonstr
direct
interact
five
member
pvrbp
thought
play
essenti
role
reticulocyt
invas
shown
first
time
avail
surfac
reticulocyt
modul
p
vivax
invas
present
evid
recent
posit
select
l
allel
express
benefici
trait
popul
expos
p
vivax
parasit
futur
studi
aim
identifi
parasit
ligand
possibl
role
interact
duffyneg
reticulocyt
invas
identif
new
molecular
interact
altern
invas
pathway
crucial
guid
ration
develop
therapeut
intervent
ie
vaccin
drug
target
reduct
prevent
reticulocyt
invas
ethic
statement
ethic
p
vivax
isol
p
vivax
isol
collect
patient
acut
p
vivax
infect
attend
clinic
shoklo
malaria
research
unit
smru
mae
sot
thailand
commun
close
iquito
citi
region
loreto
peru
sampl
blood
collect
venipunctur
lithiumheparin
tube
patient
p
vivax
malaria
monoinfect
parasit
densiti
red
blood
cell
sampl
parasit
ring
stage
plateletand
leukocytedeplet
use
column
previous
describ
purifi
parasit
frozen
glycerolyt
store
liquid
nitrogen
sampl
ship
itm
belgium
experi
perform
tabl
show
summari
p
vivax
isol
use
experi
parasit
densiti
time
collect
reticulocyteenrich
red
blood
cell
hemochromatosi
patient
reticulocyt
enrich
ml
peripher
blood
collect
hemochromatosi
patient
undergo
therapeut
phlebotomi
zna
sinterasmu
hospit
antwerp
belgium
blood
sampl
collect
sepacel
bag
freseniu
kabi
process
within
hour
follow
previous
describ
protocol
brief
pass
blood
leucocyt
deplet
filter
freseniu
kabi
connect
sepacel
blood
bag
duffi
phenotyp
fy
determin
standard
serolog
method
diamedid
micro
type
system
diam
blood
group
done
use
standard
abo
antisera
kit
diam
deplet
platelet
leukocyt
reticulocyt
concentr
centrifug
min
g
without
appli
brake
percol
minor
modif
percol
concentr
adjust
sampl
obtain
higher
reticulocyt
yield
tabl
proport
reticulocyt
calcul
thin
smear
stain
new
methylen
blue
sigma
light
microscopi
sampl
proport
reticulocyt
higher
use
p
vivax
invas
test
reticulocyt
freez
thaw
perform
previous
describ
invas
inhibit
assay
p
vivax
matur
invas
assay
perform
previous
describ
briefli
thaw
p
vivax
parasit
cultur
schizont
stage
matur
schizont
concentr
centrifug
minut
g
percol
solut
yield
enrich
schizont
concentr
matur
schizont
mix
rerbc
sampl
schizont
rerbc
ratio
cultiv
mccoy
medium
invitrogen
supplement
human
serum
glucos
h
invas
inhibit
assay
set
cultur
plate
final
volum
per
well
parasit
cultur
monitor
microscop
examin
giemsastain
thin
film
invas
rate
defin
percentag
p
vivax
ringstag
invad
rbc
per
rbc
hour
postinvas
invas
inhibit
measur
pair
rerbc
sampl
treat
vs
untreat
control
well
use
parasit
isol
invas
assay
consid
valid
parasitemia
untreat
control
well
one
except
erythrocyt
invas
p
falciparum
parasit
use
posit
control
rerbc
invas
use
commerci
avail
cat
r
system
usa
suppli
lyophil
power
steril
condit
without
hazard
preserv
constitut
steril
pb
per
manufactur
instruct
perform
invas
inhibit
concentr
describ
previou
p
falciparum
experi
bovin
serum
albumin
bsa
pb
control
use
assess
specif
assay
nonhazard
effect
nondialyz
protein
test
p
falciparum
invas
assay
compar
dialyz
protein
pair
comparison
invas
rate
treatment
analyz
use
nonparametr
wilcoxon
sign
rank
test
stata
enzymat
treatment
red
blood
cell
enzymat
treatment
reticulocyteenrich
sampl
perform
incub
cell
suspens
mgml
trypsin
bovin
pancrea
sigma
mg
ml
chymotrypsin
bovin
pancrea
sigma
uml
neuraminidas
vibrio
cholera
sigma
hour
enzymat
cleavag
effici
test
facscalibur
flow
cytomet
bd
bioscienc
neuraminidas
treatment
assess
perform
agglutin
test
use
lectin
peanut
arachi
hypogaea
detect
tantigen
expos
sialic
acid
cleavag
flow
cytometri
express
level
quantifi
facscalibur
flow
cytomet
briefli
cell
incub
monoclon
mous
antihuman
mab
biolegend
monoclon
mous
antihuman
bd
bioscienc
monoclon
mous
antihuman
darcduffi
antigenfitc
lsbio
one
hour
room
temperatur
iggfitc
conjug
antibodi
use
neg
control
protein
level
express
mfi
figur
protein
express
purif
dna
sequenc
encod
amino
acid
amino
acid
amino
acid
amino
acid
amino
acid
codonoptim
sali
protein
sequenc
escherichia
coli
express
insert
pproex
htb
express
vector
life
technolog
protein
express
purif
perform
describ
earlier
immunoprecipit
assay
recombin
pvrbp
kda
incub
mgml
reaction
volum
hour
room
temperatur
monoclon
antibodi
atcc
ad
mixtur
mgml
hour
follow
addit
incub
pack
protein
g
sepharos
bead
captur
mab
bead
wash
three
time
pb
protein
elut
equival
volum
reduc
sampl
buffer
boil
three
wwwnaturecomscientificreport
wwwnaturecomscientificreport
minut
separ
sdspage
gel
immunoprecipit
eluat
fraction
sdspage
visual
use
simplyblu
safestain
life
technolog
accord
manufactur
protocol
snp
genotyp
genotyp
blood
sampl
supplement
data
perform
follow
previous
describ
protocol
primer
sequenc
amplif
condit
restrict
enzym
detail
tabl
rerbc
sampl
aliquot
dna
extract
avail
therefor
extract
rna
genotyp
pcr
perform
cdna
allel
frequenc
distribut
linkag
disequilibrium
ld
analysi
ld
assess
use
data
genom
project
phase
genotyp
data
retriev
publish
studi
inhous
genotyp
r
measur
use
ldlink
web
tool
http
analysistoolsncinihgovldlink
ensembl
databas
http
wwwensemblorgindexhtml
biallel
snp
cubex
http
wwwoegeorgsoftwar
cubex
genotyp
data
r
valu
consid
indic
signific
correl
ld
snp
snp
data
extract
publicli
avail
databas
ie
genom
project
phase
alfr
allel
frequenc
databas
us
nation
scienc
foundat
sgvp
singapor
genom
variat
project
intern
peerreview
public
tabl
comparison
perform
use
chisquar
test
p
valu
consid
signific
